Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone.
about
Luteal phase support for assisted reproduction cyclesLuteal phase support for assisted reproduction cyclesA Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilizationProgesterone and the luteal phase: a requisite to reproductionComparison of oral dydrogesterone with vaginal progesteronefor luteal support in IUI cycles: a randomized clinical trial.Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial.Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials.Dydrogesterone use in early pregnancy.A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles.Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial.A pilot study to determine whether progestogen supplementation using dydrogesterone during the first trimester will reduce the incidence of gestational hypertension in primigravidae.Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study.Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis.Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial
P2860
Q24186532-484558D7-1B6F-49E8-8523-4EB326FAE6FCQ24235807-3F6E417F-ED3C-4EBE-8F87-8CF0195B5469Q33589647-84229E35-EC8D-46B4-8194-2515DF43EDB9Q35621181-FA60BE73-6785-406E-8F54-5E780331F4D4Q36172784-7A241663-7E65-48D6-A5F8-4B6F9C079E72Q37615489-C01C22F1-9BFA-41A5-8927-6E12BE461DE4Q38636055-2ADFFF3B-BAEF-4C08-97CE-EFB11138919FQ38708094-A4A67C48-7B18-4F95-A494-82199B0088B9Q40409435-F5E4810B-94FD-4E05-B177-3FC9C0002487Q40530000-55AA0486-5AD0-44CE-98CB-1FF4215289BBQ46317434-4C87FF2C-B988-4019-B4BB-28A386497D29Q47823812-0B6938A3-93FD-416E-90DA-6A3697446AE3Q53272823-8426654A-C51B-44BF-AA42-604892416D83Q57284013-894B07F1-D420-4757-BE23-3E324D4360CD
P2860
Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Modulating fertility outcome i ...... by the use of dydrogesterone.
@en
Modulating fertility outcome i ...... by the use of dydrogesterone.
@nl
type
label
Modulating fertility outcome i ...... by the use of dydrogesterone.
@en
Modulating fertility outcome i ...... by the use of dydrogesterone.
@nl
prefLabel
Modulating fertility outcome i ...... by the use of dydrogesterone.
@en
Modulating fertility outcome i ...... by the use of dydrogesterone.
@nl
P2860
P1476
Modulating fertility outcome i ...... by the use of dydrogesterone.
@en
P2093
Ameet Patki
Vijay C Pawar
P2860
P356
10.1080/09513590701584857
P478
23 Suppl 1
P577
2007-10-01T00:00:00Z